Kanuma approval adds to Alexion rare disease rosterAlexion has gained FDA approval for Kanuma, its treatment for the rare disease lysosomal acid lipase (LAL) deficiency. Alexion Share XKanuma approval adds to Alexion rare disease rosterhttps://pharmaphorum.com/news/kanuma-approval-adds-to-alexion-rare-disease-roster/
